New Guidelines for COVID-19 Oncology Pharmacy ServicesJuly 20, 2020 | Oncology Hematology First Guidelines for Providing Oncology Pharmacy Services in COVID-19 Published in JCO Clinical Practice and developed by a working group of seven experts in oncology pharmacy practice, the guidelines outline 26 recommendations covering the use of anticancer medications, from proper staff hygiene and safety to how to conduct clinical trials. Read full article Hematology US Medical Cancer Care Costs Substantial, Expected to Increase The study looked at cancer survivors aged 65 or older from the SEER-Medicare database; survivors were diagnosed with cancer between 2000 and 2012. Claims from 2007 to 2013 were used to estimate costs by cancer site, phases of care, and stage at diagnosis. Read full article Family Medicine/General Practice Immune-Related Cutaneous Adverse Events Common in Skin of Color Patients Presented at the ASCO20 Virtual Scientific Program, data from the 1,459 patients who were African American, Hispanic, Native American, Pacific Islander, or Asian highlighted the need for increased surveillance for cutaneous toxicity in patients with darker pigmented skin. Immune-related cutaneous adverse events (irCAEs) were assessed by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS